Assay reveals potency of neutralising antibodies in COVID-19 patients
Researchers have shown that neutralising antibodies developed in COVID-19 patients were less potent if from those with severe or fatal disease.
List view / Grid view
Researchers have shown that neutralising antibodies developed in COVID-19 patients were less potent if from those with severe or fatal disease.
Using CRISPR-Cas9, scientists have developed a new method for generating mouse lines for vaccine research in just a few weeks.
Dr Diogo Camacho from the Wyss Institute at Harvard discusses new research into using machine learning algorithms to analyse RNA sequences and reveal potential drug targets.
Using atomistic simulations, a team has demonstrated how coronavirus Spike proteins move and vibrate to let the virus through cell walls.
A research team has developed a potentially universal flu vaccine that has demonstrated success in mice.
The novel protocol allows proteins over 100 amino acids long to be synthesised in hours and include amino acids that do not occur in the human proteome.
Two studies reveal the importance of timing in Huntington’s disease interventions and demonstrate interleukin-6 may play a protective role.
Researchers who developed modified proteins say this could be used in the fight against COVID-19, by tackling cytokine storms.
Researchers at MIT have developed a mathematical model that can calculate whether diabetes treatments in pre-clinical trials will be successful in humans.
A new antibiotic compound has been identified by researchers who designed a machine-learning algorithm to screen millions of molecules.
Researchers have conducted a genetic screen in mice to discover a family of genes that contributes to the development of Huntington's.
Drug Target Review lists its 10 most popular news stories from 2019, summarising the drug targets that you wanted to read about.
Glycans, which are found in mucus, have the ability to regulate how microbes behave and could lead to new therapeutics.
A new platform combines AI, flow chemistry and robotics to minimise the need for human intervention in the synthesis process.
A new study has found that damage caused by Alzheimer's allows toxins to enter the brain, further harming neurons.